These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34547923)

  • 21. Therapeutic benefit of second-look transurethral resection of bladder tumors for newly diagnosed T1 bladder cancer: a single-center experience.
    Tseng WH; Liu CL; Huang SK; Liao AC; Kuo JR; Hun SH; Chen CH; Su CC; Wang JC; Lee KH; Shen KH; Li CF
    Int Urol Nephrol; 2019 Aug; 51(8):1335-1342. PubMed ID: 31129781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of T1 Bladder Cancer on Biopsy and Transurethral Resection Specimens: Comparison and Ranking of T1 Quantification Approaches to Predict Progression to Muscularis Propria Invasion.
    Leivo MZ; Sahoo D; Hamilton Z; Mirsadraei L; Shabaik A; Parsons JK; Kader AK; Derweesh I; Kane C; Hansel DE
    Am J Surg Pathol; 2018 Jan; 42(1):e1-e10. PubMed ID: 29076872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does the management of bladder perforation during transurethral resection of superficial bladder tumors predispose to extravesical tumor recurrence?
    Skolarikos A; Chrisofos M; Ferakis N; Papatsoris A; Dellis A; Deliveliotis C
    J Urol; 2005 Jun; 173(6):1908-11. PubMed ID: 15879773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current concept of transurethral resection of bladder cancer: from re-transurethral resection of bladder cancer to en-bloc resection.
    Schraml J; Silva JDC; Babjuk M
    Curr Opin Urol; 2018 Nov; 28(6):591-597. PubMed ID: 30102624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radical cystectomy for stages Ta, Tis and T1 transitional cell carcinoma of the bladder.
    Amling CL; Thrasher JB; Frazier HA; Dodge RK; Robertson JE; Paulson DF
    J Urol; 1994 Jan; 151(1):31-5; discussion 35-6. PubMed ID: 8254828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder.
    Zietman AL; Grocela J; Zehr E; Kaufman DS; Young RH; Althausen AF; Heney NM; Shipley WU
    Urology; 2001 Sep; 58(3):380-5. PubMed ID: 11549485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [T1 bladder cancer: role of documentation for bladder tumor findings and targeted second resection].
    Lazica DA; Böttcher S; Degener S; von Rundstedt FC; Brandt AS; Störkel S; Roth S
    Urologe A; 2013 Aug; 52(8):1110-7. PubMed ID: 23754611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple adverse histological features increase the odds of under staging T1 bladder cancer.
    Weizer AZ; Wasco MJ; Wang R; Daignault S; Lee CT; Shah RB
    J Urol; 2009 Jul; 182(1):59-65; discussion 65. PubMed ID: 19447443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
    Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
    J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repeat Transurethral Resection in Non-muscle-invasive Bladder Cancer: A Systematic Review.
    Cumberbatch MGK; Foerster B; Catto JWF; Kamat AM; Kassouf W; Jubber I; Shariat SF; Sylvester RJ; Gontero P
    Eur Urol; 2018 Jun; 73(6):925-933. PubMed ID: 29523366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do we need a re-TUR after en bloc resection of T1 stage bladder cancer?
    Levy S; Péricart S; Bajeot AS; Fakhfakh S; Lesourd M; Soulié M; Pignot G; Roumiguié M
    World J Urol; 2024 Aug; 42(1):475. PubMed ID: 39115589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The value of a second transurethral resection for T1 bladder cancer.
    Schwaibold HE; Sivalingam S; May F; Hartung R
    BJU Int; 2006 Jun; 97(6):1199-201. PubMed ID: 16566814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Second Transurethral Resection of Bladder Tumor: Is it Necessary in All T1 and/or High-Grade Tumors?
    Ayati M; Amini E; Shahrokhi Damavand R; Nowroozi MR; Soleimani M; Ranjbar E; Nowroozi A
    Urol J; 2019 May; 16(2):152-156. PubMed ID: 30251745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A clinicopathologic study of gynecologic organ involvement at radical cystectomy for bladder cancer.
    Salem H; El-Mazny A
    Int J Gynaecol Obstet; 2011 Nov; 115(2):188-90. PubMed ID: 21872241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.
    Babjuk M; Burger M; Zigeuner R; Shariat SF; van Rhijn BW; Compérat E; Sylvester RJ; Kaasinen E; Böhle A; Palou Redorta J; Rouprêt M;
    Eur Urol; 2013 Oct; 64(4):639-53. PubMed ID: 23827737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The impact of restaging transurethral resection on recurrence and progression free survival in patients with T1 high grade bladder cancer].
    Brun A; Koutlidis N; Thibault T; Escoffier A; Bardet F; Cormier L
    Prog Urol; 2023 Mar; 33(3):125-134. PubMed ID: 36604247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conservative management of muscle-infiltrating bladder cancer: prospective experience.
    Herr HW
    J Urol; 1987 Nov; 138(5):1162-3. PubMed ID: 3669160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bladder cancer--resection/ablation.
    Corica FA; Keane TE
    Surg Oncol Clin N Am; 2005 Apr; 14(2):321-52. PubMed ID: 15817242
    [No Abstract]   [Full Text] [Related]  

  • 39. Early versus deferred cystectomy for initial high-risk pT1G3 urothelial carcinoma of the bladder: do risk factors define feasibility of bladder-sparing approach?
    Denzinger S; Fritsche HM; Otto W; Blana A; Wieland WF; Burger M
    Eur Urol; 2008 Jan; 53(1):146-52. PubMed ID: 17624657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncologic Surveillance for Variant Histology Bladder Cancer after Radical Cystectomy.
    Martini A; Afferi L; Zamboni S; Schultz JG; Lonati C; Mattei A; Karnes RJ; Soligo M; Stabile A; Di Trapani E; De Cobelli O; Simone G; Simeone C; Alvarez-Maestro M; Gandaglia G; Gallina A; Colombo R; Briganti A; Montorsi F; Xylinas E; Shariat SF; Moschini M
    J Urol; 2021 Oct; 206(4):885-893. PubMed ID: 34032498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.